Combined phase I/II study of imexon (AOP99.0001) for treatment of relapsed or refractory multiple myeloma-Reference-Cited by-同舟云学术

Combined phase I/II study of imexon (AOP99.0001) for treatment of relapsed or refractory multiple myeloma

Published:2010-08 Issue:7 Volume:21 Page:708-715
ISSN:0959-4973
Container-title:Anti-Cancer Drugs
language:en
Short-container-title:

Author:

Moehler Thomas M.,Feneberg Reinhard,Ho Anthony Dick,Golenkov Anatoly K.,Ludwig Heinz,Kropff Martin,Khuageva Nuriet K.,Hajda Jacek,von Broen Ingo,Goldschmidt Hartmut

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology (medical),Pharmacology,Oncology

Reference15 articles.

1. Improved survival of patients with multiple myeloma after the introduction of novel agents and the applicability of the International Staging System (ISS): an analysis of the Greek Myeloma Study Group (GMSG);Kastritis;Leukemia,2009

2. Salvage therapy for multiple myeloma with thalidomide and CED chemotherapy;Moehler;Blood,2001

3. Improved survival in multiple myeloma and the impact of novel therapies;Kumar;Blood,2008

4. Immune modulation and control of neoplasia by adjuvant therapy;Bicker,1978

5. Antitumor activity of imexon;Sagaster;J Natl Cancer Inst,1995

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic outcome of early-phase clinical trials in multiple myeloma: a meta-analysis;Blood Cancer Journal;2021-03

2. Glutathione system in animal model of solid tumors: From regulation to therapeutic target;Critical Reviews in Oncology/Hematology;2018-08

3. A Phase 2 Randomized, Double-Blind, Multicenter Trial of Imexon Plus Gemcitabine Versus Gemcitabine Plus Placebo in Patients With Metastatic Chemotherapy-naïve Pancreatic Adenocarcinoma;American Journal of Clinical Oncology;2018-03

4. Phase 2 study of imexon, a prooxidant molecule, in relapsed and refractory B-cell non-Hodgkin lymphoma;Blood;2014-08-21

5. Chemistry and Pharmacology of Imexon and Related Cyanoaziridines;Current Medicinal Chemistry;2012-11-14